4//SEC Filing
Shetzline Michael 4
Accession 0001209191-22-031842
CIK 0001446847other
Filed
May 24, 8:00 PM ET
Accepted
May 25, 4:05 PM ET
Size
6.8 KB
Accession
0001209191-22-031842
Insider Transaction Report
Form 4
Shetzline Michael
SVP, CMO, Head-Res&Drug
Transactions
- Sale
Class A Common Stock
2022-05-23$11.50/sh−3,130$35,995→ 273,698 total - Sale
Class A Common Stock
2022-05-23$11.50/sh−7,453$85,710→ 266,245 total
Footnotes (2)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 33.33% of the reporting person's restricted stock units granted on April 24, 2020.
- [F2]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 50% of the reporting person's restricted stock units granted on March 26, 2021.
Documents
Issuer
IRONWOOD PHARMACEUTICALS INC
CIK 0001446847
Entity typeother
Related Parties
1- filerCIK 0001808509
Filing Metadata
- Form type
- 4
- Filed
- May 24, 8:00 PM ET
- Accepted
- May 25, 4:05 PM ET
- Size
- 6.8 KB